TY - JOUR
T1 - Prospects for peptidomimetic drug design
AU - Hruby, V. J.
N1 - Funding Information: The constant constructive criticism of my students, collaborators and colleagues in the development of these ideas is gratefully acknowledged, as well as the support by grants from the US Public Health Servicea nd NIDA, who are not responsible for the ideas expressed in this discussion.
PY - 1997
Y1 - 1997
N2 - Peptidomimetic drug design offers many exciting opportunities and challenges for the basic research scientist interested in understanding the chemical and physical principles critical for drug action, and for medicinal chemists, biochemists, molecular biologists and others to apply these principles to the next-generation of drugs. Considerable success already has been achieved, and it is likely that continued research in peptide and protein structural chemistry, coupled with the development of novel scaffolds and templates that can predictably mimic the stereoelectronic, stereostructural and dynamic properties of peptides and proteins, will provide the tools for successful de novo peptidomimetic design.
AB - Peptidomimetic drug design offers many exciting opportunities and challenges for the basic research scientist interested in understanding the chemical and physical principles critical for drug action, and for medicinal chemists, biochemists, molecular biologists and others to apply these principles to the next-generation of drugs. Considerable success already has been achieved, and it is likely that continued research in peptide and protein structural chemistry, coupled with the development of novel scaffolds and templates that can predictably mimic the stereoelectronic, stereostructural and dynamic properties of peptides and proteins, will provide the tools for successful de novo peptidomimetic design.
UR - http://www.scopus.com/inward/record.url?scp=0030798713&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030798713&partnerID=8YFLogxK
U2 - 10.1016/S1359-6446(96)20009-1
DO - 10.1016/S1359-6446(96)20009-1
M3 - Editorial
SN - 1359-6446
VL - 2
SP - 165
EP - 167
JO - Drug discovery today
JF - Drug discovery today
IS - 5
ER -